Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.

Tselikas L, Susini S, Texier M, Yurchenko A, Routier E, Amini-Adle M, Tihic E, Mouraud S, Danlos FX, Ammari S, Raoult T, Roy S, Bredel D, Farhane S, Cassard L, Molinaro I, Eggermont A, Soria JC, Zitvogel L, Massard C, Paci A, de Baere T, Scoazec JY, Chaput N, Nikolaev S, Meyer N, Lebbé C, Dalle S, Robert C, Marabelle A

Open source

DOI: 10.1038/s41586-026-10341-w
Published: 2026 Jul
Container: Nature
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41586-026-10341-w,
  title = {Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.},
  author = {Tselikas L and Susini S and Texier M and Yurchenko A and Routier E and Amini-Adle M and Tihic E and Mouraud S and Danlos FX and Ammari S and Raoult T and Roy S and Bredel D and Farhane S and Cassard L and Molinaro I and Eggermont A and Soria JC and Zitvogel L and Massard C and Paci A and de Baere T and Scoazec JY and Chaput N and Nikolaev S and Meyer N and Lebbé C and Dalle S and Robert C and Marabelle A},
  year = {2026},
  journal = {Nature},
  doi = {10.1038/s41586-026-10341-w},
  url = {https://doi.org/10.1038/s41586-026-10341-w}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.
AU  - Tselikas L
AU  - Susini S
AU  - Texier M
AU  - Yurchenko A
AU  - Routier E
AU  - Amini-Adle M
AU  - Tihic E
AU  - Mouraud S
AU  - Danlos FX
AU  - Ammari S
AU  - Raoult T
AU  - Roy S
AU  - Bredel D
AU  - Farhane S
AU  - Cassard L
AU  - Molinaro I
AU  - Eggermont A
AU  - Soria JC
AU  - Zitvogel L
AU  - Massard C
AU  - Paci A
AU  - de Baere T
AU  - Scoazec JY
AU  - Chaput N
AU  - Nikolaev S
AU  - Meyer N
AU  - Lebbé C
AU  - Dalle S
AU  - Robert C
AU  - Marabelle A
PY  - 2026
JO  - Nature
DO  - 10.1038/s41586-026-10341-w
UR  - https://doi.org/10.1038/s41586-026-10341-w
ER  -

APA

L, T., S, S., M, T., A, Y., E, R., M, A., E, T., S, M., FX, D., S, A., T, R., S, R., D, B., S, F., L, C., I, M., A, E., JC, S., L, Z., C, M., A, P., T, D. B., JY, S., N, C., S, N., N, M., C, L., S, D., C, R., & A, M. (2026). Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.. Nature. https://doi.org/10.1038/s41586-026-10341-w

Source records

pubmed · retrieved 2026-09-27T09:23:45.404Z
europe-pmc · retrieved 2026-09-27T09:23:45.407Z
hal · retrieved 2026-09-27T09:23:45.471Z